Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference Call
July 14 2005 - 12:11PM
PR Newswire (US)
Biosite(R) Incorporated to Conduct 2nd Quarter Results Conference
Call SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Biosite
Incorporated (NASDAQ:BSTE) announces the following Webcast: Biosite
Incorporated will announce 2005 second quarter results on Tuesday,
July 26, 2005 following the close of the market. The Company will
also webcast a conference call on the same day (July 26) at 1:30
p.m. Pacific. What: Biosite Announces 2nd Quarter Results
Conference Call When: Tuesday, July 26, 2005 at 1:30 p.m. Pacific
Where: http://phx.corporate-ir.net/phoenix.zhtml?p=irol-
eventDetails&c=69046&eventID=1100191 OR
http://www.biosite.com/ How: Live over the Internet -- Simply log
onto the web at the address above. Telephonic: US/Canada/Int'l Dial
#: (706) 634-7088 Conference ID# 7772745 You may dial *0 at any
time for Operator assistance Contact: Simona Dixon Corporate and
Investor Relations Biosite Incorporated 858.455.4808 ext. 3221
email: If you are unable to participate during the live webcast,
the call will be archived on the Biosite web site
http://www.biosite.com/ until August 16th, 2005. The telephone
replay number for U.S. callers is 800-642-1687. International
callers can dial 706-645-9291, conference ID# 7772745. Company
press releases may be found at http://www.biosite.com/ About
Biosite: A leader in the drive to advance diagnosis, Biosite
Incorporated is a research-based company dedicated to the discovery
and development of novel protein-based diagnostic tests that
improve a physician's ability to diagnose debilitating and
life-threatening diseases. The Company combines integrated
discovery and diagnostics businesses to access proteomics research,
identify proteins with high diagnostic utility, develop and
commercialize products and educate the medical community on new
diagnostic approaches that improve health care outcomes. Biosite's
Triage(R) brand rapid diagnostic tests are used in approximately 50
percent of U.S. hospitals and in more than 50 international
markets. Biosite's commercialized products include the Triage BNP
Test to aid in the diagnosis and severity assessment of heart
failure, the Triage Cardiac Panel to aid in the diagnosis of heart
attacks and the Triage Drugs of Abuse Products for the diagnosis of
drug overdose. These tests can deliver critical diagnostic
information to physicians within 10 to 20 minutes. Information
about Biosite can be found at http://www.biosite.com/. (Minimum
Requirements to listen to broadcast: The Windows Media Player
software, downloadable free from:
http://www.microsoft.com/windows/windowsmedia/EN/default.asp and at
least a 28.8Kbps connection to the Internet.) DATASOURCE: Biosite
Incorporated CONTACT: Nadine Padilla, VP, Corporate & Investor
Relations of Biosite Incorporated, +1-858-455-4808, ext. 3187, Web
site: http://www.biosite.com/ Company News On-Call:
http://www.prnewswire.com/comp/116737.html
Copyright
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosite (NASDAQ:BSTE)
Historical Stock Chart
From Jul 2023 to Jul 2024